|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6 HKD | -4.76% |
|
-4.76% | -4.76% |
| 23/04 | Kingworld Medicines Posts 68% Jump in 2023 Profit | MT |
| 27/03 | Kingworld Medicines Group Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 28 June 2024 | CI |
Kingworld Medicines Group Limited reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 419.65 million compared to CNY 415.3 million a year ago. Net income was CNY 24.21 million compared to CNY 19.48 million a year ago.
Basic earnings per share from continuing operations was CNY 0.0399 compared to CNY 0.0321 a year ago. Diluted earnings per share from continuing operations was CNY 0.0399 compared to CNY 0.0321 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -4.76% | 47.8M | |
| +21.11% | 72.89B | |
| -4.38% | 23.48B | |
| +4.65% | 8.67B | |
| +10.16% | 8.51B | |
| -22.99% | 7.71B | |
| +13.25% | 5.21B | |
| +1.58% | 4.23B | |
| +1.03% | 3.99B | |
| +10.84% | 4.08B |
KINGWORLD MEDICINES GROUP LIMITED 
